Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · IEX Real-Time Price · USD
12.29
+0.12 (0.99%)
At close: Jul 19, 2024, 4:00 PM
12.30
+0.01 (0.08%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
Sage Therapeutics Employees
Sage Therapeutics had 487 employees as of December 31, 2023. The number of employees decreased by 202 or -29.32% compared to the previous year.
Employees
487
Change (1Y)
-202
Growth (1Y)
-29.32%
Revenue / Employee
$186,990
Profits / Employee
-$1,033,150
Market Cap
739.64M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 487 | -202 | -29.32% |
Dec 31, 2022 | 689 | 218 | 46.28% |
Dec 31, 2021 | 471 | 173 | 58.05% |
Dec 31, 2020 | 298 | -377 | -55.85% |
Dec 31, 2019 | 675 | 38 | 5.97% |
Dec 31, 2018 | 637 | 380 | 147.86% |
Dec 31, 2017 | 257 | 122 | 90.37% |
Dec 31, 2016 | 135 | 73 | 117.74% |
Dec 31, 2015 | 62 | 31 | 100.00% |
Dec 31, 2014 | 31 | 8 | 34.78% |
Dec 31, 2013 | 23 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Travere Therapeutics | 380 |
Lexicon Pharmaceuticals | 285 |
Evolus | 273 |
Wave Life Sciences | 268 |
Pliant Therapeutics | 158 |
4D Molecular Therapeutics | 147 |
CARGO Therapeutics | 116 |
Stoke Therapeutics | 110 |
SAGE News
- 2 days ago - Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Violations And Investors With Losses Are Urged To Start Dialogues - Accesswire
- 3 days ago - The Schall Law Firm Is Investigating Sage Therapeutics Inc For Potential Securities Breaches And Encourages Investors Who Have Experienced Losses To Initiate Dialogues - Accesswire
- 4 days ago - Sage Therapeutics Inc Is Under Examination For Possible Securities Violations By The Schall Law Firm, Investors Who Have Suffered Losses Are Urged To Begin Conversations - Accesswire
- 5 days ago - Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024 - Business Wire
- 5 days ago - The Schall Law Firm Encourages Investors With Losses To Initiate Dialogue, Sage Therapeutics Inc Is Under Scrutiny For Potential Securities Violations - Accesswire
- 6 days ago - Sage Therapeutics Inc Under Investigation By The Schall Law Firm For Possible Securities Breaches Urging Investors With Losses To Start Conversation - Accesswire
- 8 days ago - The Schall Law Firm Begins Investigation Into Sage Therapeutics Inc For Potential Securities Violations And Urges Investors With Losses To Initiate Conversation - Accesswire
- 9 days ago - Inquiry Into Sage Therapeutics Inc For Possible Securities Breaches Initiated By The Schall Law Firm Encouraging Investors With Losses To Start Dialogue - Accesswire